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Abstract
Aims/hypothesis South Asian individuals have reduced insu-
lin sensitivity and increased risk of type 2 diabetes compared
with white individuals. Temporal changes in glycaemic traits
during middle age suggest that impaired insulin secretion is a
particular feature of diabetes development among South
Asians. We therefore aimed to examine ethnic differences in
early changes in glucose metabolism prior to incident type 2
diabetes.
Methods In a prospective British occupational cohort, subject to
5 yearly clinical examinations, we examined ethnic differences in
trajectories of fasting plasma glucose (FPG), 2 h post-load plas-
ma glucose (2hPG), fasting serum insulin (FSI), 2 h post-load
serum insulin (2hSI), HOMA of insulin sensitivity (HOMA2-S)
and secretion (HOMA2-B), and the Gutt insulin sensitivity index
(ISI0,120) among 120 South Asian and 867 white participants
who developed diabetes during follow-up (1991–2013). We
fitted cubic mixed-effects models to longitudinal data with ad-
justment for a wide range of covariates.
Results Compared with white individuals, South Asians had a
faster increase in FPG before diagnosis (slope difference
0.22 mmol/l per decade; 95% CI 0.02, 0.42; p = 0.03) and a
higher FPG level at diagnosis (0.27 mmol/l; 95% CI 0.06,
0.48; p = 0.01). They also had higher FSI and 2hSI levels
before and at diabetes diagnosis. South Asians had a faster
decline and lower HOMA2-S (loge-transformed) at diagnosis
compared with white individuals (0.33; 95% CI 0.21, 0.46;
p < 0.001). HOMA2-B increased in both ethnic groups until
7 years before diagnosis and then declined; the initial increase
was faster in white individuals. ISI0,120 declined steeply in
both groups before diagnosis; levels were lower among
South Asians before and at diagnosis. There were no ethnic
differences in 2hPG trajectories.
Conclusions/interpretation We observed different trajectories
of plasma glucose, insulin sensitivity and secretion prior to
diabetes diagnosis in South Asian and white individuals.
This might be due to ethnic differences in the natural history
of diabetes. South Asian individuals experienced a more rapid
decrease in insulin sensitivity and faster increases in FPG
compared with white individuals. These findings suggest
more marked disturbance in beta cell compensation prior to
diabetes diagnosis in South Asian individuals.
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Introduction
Pathophysiological changes leading to type 2 diabetes and
macrovascular complications begin to develop well before
current cut-off levels for impaired fasting glucose, impaired
glucose tolerance and diabetes [1–3]. This increased risk dif-
fers by ethnic group. In the UK, individuals of South Asian
descent, for example, have a substantially higher risk of de-
veloping type 2 diabetes compared with individuals of
European descent [4]. There is robust evidence that reduced
insulin sensitivity contributes to this elevated risk [5–7]. Beta
cell dysfunction is also a plausible aetiological factor
explaining elevated risk among South Asian individuals [8,
9]. First, fetal undernutrition is common in Asian populations,
which could lead to reduced pancreatic growth and lower
insulin secretion levels [3, 10]. Second, reduced insulin sen-
sitivity is observed in South Asians from early life and could
contribute to inadequate insulin secretion through gluco- and
lipotoxicity [11]. However, conducting population-based
studies on beta cell function is challenging because measures
of insulin secretion based on fasting plasma glucose (FPG) or
the OGTT do not account for the dependence of insulin secre-
tion on blood glucose levels and underlying insulin sensitivity
[12, 13].
Recent advancements in longitudinal modelling allow es-
timation of changes in beta cell function by examining trajec-
tories of insulin sensitivity and insulin secretion together over
time. We have previously identified a long ‘compensatory’
period in the pathophysiology leading to diabetes. This is
characterised by increasing insulin secretion, which compen-
sates for insulin resistance while keeping glucose values stable
[14]. We have also identified subgroups with different trajec-
tories of insulin sensitivity and secretion prior to the develop-
ment of diabetes, suggesting important heterogeneity in the
relative contributions of insulin sensitivity and secretion be-
fore diagnosis of type 2 diabetes [15]. Longitudinal modelling
of age-related changes in insulin sensitivity and insulin secre-
tion among individuals without diabetes has shown a lack of
compensatory increase in insulin secretion among South
Asian compared with white individuals, supporting the hy-
pothesis of a reduced pancreatic functional reserve in this
high-risk group [3]. However, ethnic differences in the natural
history of early changes in glucose metabolism prior to inci-
dent type 2 diabetes are not well understood, precluding opti-
mal timing for screening and prevention activities among
South Asian people.
In this prospective study with repeat assessments of
glycaemic traits, we used longitudinal modelling to examine
ethnic differences in trajectories of FPG and 2 h post-load
plasma glucose (2hPG), fasting serum insulin (FSI) and 2 h
post-load insulin (2hSI), HOMA of insulin sensitivity
(HOMA2-S) and secretion (HOMA2-B), and the Gutt insulin
sensitivity index (ISI0,120) prior to diabetes diagnosis in a UK
population of Europid or South Asian ethnicity.
Methods
Study population and design The Whitehall II study was set
up in 1985. All non-industrial British civil servants aged 35–
55 years and working in London offices were invited to take
part. The response rate was 73%, with 10,308 participants
attending an initial clinical examination and completing self-
administered questionnaires (phase 1). During follow-up, 5
yearly clinical examinations were performed and additional
questionnaire-only phases were conducted until 2012–2013
(phase 11). The University College London Ethics
Committee reviewed and approved the study. Written in-
formed consent was obtained from all participants at each
study phase.
OGTTs were first performed at phase 3 (1991–1994), serving
as the baseline for our analyses (n = 8815). OGTTs took place in
either the morning or afternoon, following ≥8 h and ≥5 h of
fasting, respectively. We excluded the following individuals:
those from ethnic groups other than South Asian or white
(n = 397); those with prevalent diabetes or missing follow-up
data on diabetes status (n = 516); those who remained free of
diabetes during the study (n = 6801); those who did not provide
any fasting samples according to the Whitehall II protocol
(n = 47); and those with missing covariate information, e.g. data
on BMI, diet, physical activity and employment grade (n = 67).
The final sample consisted of 120 South Asian and 867 white
individuals who developed diabetes during a median (inter-
quartile range) follow-up of 13.2 (9.9–16.4) years. Diabetes
was diagnosed either by a doctor outside the study or during
the clinical examination according to WHO epidemiological
criteria [16, 17]. FPG values were available in all phases of
the study; 2hPG was available in all but the final phase
(phase 11). HbA1c measures were available from phase 7
onwards. For doctor-diagnosed diabetes, the date of diagnosis
was defined as the midpoint between the date of the last
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screening and the date of the phase when the participant
reported diagnosed diabetes.
Measurements Fasting and 2 h post-load venous blood sam-
ples were taken during a 75 g OGTTaccording to standardised
protocols. Blood glucose was measured with the glucose
oxidase method (YSI Corporation, Yellow Springs, OH,
USA). Serum insulin was measured with an in-house human
insulin RIA and later with an ELISA kit (Dako Cytomation,
Ely, UK) [14]. HOMA2-S and HOMA2-B were calculated
with the HOMA2 calculator, version 2.2 (www.dtu.ox.ac.uk/
homacalculator/index.php) using FPG and FSI values [18].
ISI0,120 was calculated using the equation developed by Gutt
et al [19]. BMI was measured according to standardised
protocols. Ethnicity was defined using Office for National
Statistics 1991 census types. We used self-reported ethnicity
from phase 5; missing data were complemented by observer-
assigned ethnicity from phase 1. Rates of agreement between
observer-assigned and self-reported ethnicity were high (93%
for South Asian and 99.3% for white individuals). South
Asians were defined as individuals of Indian, Sri Lankan,
Pakistani or Bangladeshi ethnic origin. We used British Civil
Service employment grade as a measure of occupational sta-
tus. This was grouped into three categories: high (senior ad-
ministrators), intermediate (executives, professionals and tech-
nical staff) and low (clerical and office support staff). Physical
activity was assessed by questions on the frequency and duration
of participation in physical activity at different intensities and
grouped into three categories: inactive, moderately active and
active. Global dietary patterns were derived from the type of
bread and milk most frequently consumed and the frequency
of fruit and vegetable consumption (on an eight-point scale).
The dietary score classified participants into three groups:
healthy (three points), moderately healthy (between four
and seven points) or unhealthy (eight or more points).
Assessment of lifestyle factors has been described previously
[20].
Statistical analyses We described and compared baseline
characteristics between the two ethnic groups. FSI, 2hSI,
HOMA2-S, HOMA2-B and ISI0,120 were loge-transformed be-
cause of their skewed distribution. Linear (t), quadratic (t2) or
cubic (t3) trajectories were assessed by fitting mixed-effects
models, depending on which form best fitted the data. These
models use all available data and do not require the same number
of measurements per person or the same time points. They also
take into account the within-person correlation arising from the
longitudinal nature of the data. The time variable of the models
was defined as follows: the date of diagnosis was set to year 0
and all measurements that were taken before this date were in-
cluded retrospectively until the first clinical examination. First,
we modelled differences in glycaemic trajectories between white
and South Asian individuals by including ethnicity as a binary
variable (South Asian/white) in the models along with its inter-
actions with all the time terms (linear, quadratic, cubic). All
models were adjusted for age at diagnosis and sex. When the
ethnicity by cubic time interaction was not significant, the model
was refitted without this term. Then we tested the ethnicity by
quadratic time term the sameway and decided on inclusion based
on statistical significance of the interaction term. The ethnicity by
first order time interaction was always retained in the model
regardless of its statistical significance. Second, we further
adjusted the models for time-varying BMI, diet and physical
activity, and for baseline employment grade. To compare the
models, we used the same specification for these multivariable
adjusted models as for the age- and sex-adjusted models. In a
sensitivity analysis, we compared all models with and without
adjustment for age and BMI. All statistical analyses were
performed in R, version 3.0.1 (R Foundation for Statistical
Computing, Vienna, Austria). Statistical significance was
inferred at a two-tailed p value <0.05.
Results
The 120 South Asian and 867 white individuals who developed
diabetes between 1991 and 2013 contributed a total of 2140
fasting measurements to our analysis. Median follow-up time
was 13.1 years for South Asian and 13.2 years for white
individuals. The median age at diabetes diagnosis was 63 years;
this did not differ by ethnic group (p = 0.97). There was a small
difference in the mode by which South Asian and white
individuals were diagnosed, i.e. by screening or clinical diag-
nosis (screening 43% vs 54%, respectively; p = 0.03). There
were no ethnic differences in the proportion of individuals
diagnosed via OGTT in the morning or afternoon (p = 0.73).
Participant characteristics at baseline are summarised by
ethnic group in Table 1. Compared with their counterparts of
European descent, South Asian participants were 1 year older
and more likely to be female. They were more likely to have a
low occupational grade, exhibit low physical activity levels
and follow an unhealthy diet.
Figure 1 shows glucose and insulin trajectories (FPG,
2hPG, FSI and 2hSI) prior to diagnosis of diabetes in each
ethnic group, while Fig. 2 shows the insulin sensitivity and
secretion trajectories (HOMA2-S, HOMA2-B and ISI0,120).
Coefficients of the best fitting trajectories are shown in
Tables 2 and 3. Cubic models provided better model fit for
FPG, 2hPG, HOMA2-B and ISI0,120. By contrast, adding a
cubic term did not improve model fit for FSI and HOMA2-S.
A linear model best described changes in 2hSI over time.
Among both ethnic groups, there were small increases in FPG
over time, with a slightly larger increase among South Asian
compared with white individuals (slope difference 0.22 mmol/l
per decade; 95% CI 0.02, 0.42; p = 0.03) (Table 2). This group
exhibited higher FPG levels at diagnosis (0.27 mmol/l; 95% CI
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0.06, 0.48; p = 0.01). Most of the increases in FPG were ob-
served during the 3–4 years before diabetes diagnosis.
There were large increases in 2hPG over time in both ethnic
groups. Trajectories of 2hPG did not differ between ethnic
groups (slope difference 0.21 mmol/l per decade; 95% CI
−0.25, 0.67; p = 0.37) (Table 2). The 2hPG cubic trajectory
was characterised by a steep rise from approximately 7 to
12 mmol/l in the last 6 years prior to diagnosis. Levels of FSI
and 2hSI were higher among South Asian compared with white
individuals before and at diabetes diagnosis. The shape of the
2hSI trajectory was similar in both ethnic groups, while the FSI
curve exhibited some differences (p < 0.05 for t2 × ethnicity
interaction).
HOMA2-S levels were higher among white compared with
South Asian individuals throughout the follow-up period
(geometric mean difference 28%) (Table 3). There was a linear
decrease in HOMA2-S during follow-up in both ethnic
groups, with levels declining from 79.8 to 74.2 among white
individuals and from 63.0 to 53.1 among South Asians
10 years before diagnosis. This decline was steeper in the
South Asian group from 10 years before diagnosis; however,
ethnic difference in the shape of the trajectories became non-
significant in the most adjusted model.
Insulin secretion levels were higher among South Asian
compared with white individuals throughout the follow-up
period. There was a modest increase in HOMA2-B levels in
both ethnic groups until 7 years before diagnosis. This initial
increase was 7.3% (95% CI 0.6, 14.1) faster among white
individuals. Insulin secretion then declined in both ethnic
groups in a quadratic trajectory until diagnosis (Table 3).
ISI0,120 levels were 17.4% (95% CI 7.3, 31.0; geometric
mean difference) lower among South Asian compared with
white individuals before and at diagnosis; however, the shape
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Fig. 1 Trajectories of (a) FPG,
(b) 2hPG, (c) FSI and (d) 2hSI,
with 95% CIs, by ethnic group
(red circles, South Asians; blue
squares, whites). All models were
adjusted for age, sex, BMI,
employment grade, diet and
physical activity. Insulin values
were loge-transformed before
fitting the models and then
transformed back to the original
scale
Table 1 Baseline characteristics of study participants by ethnicity
Variable White South Asian
n 867 120
Age, years 50 (45–56) 51 (46–55)
Male, % 74 63
BMI, kg/m2 26.3 (24.4–29.3) 24.9 (23.5–28.0)
FPG, mmol/l 5.4 (5.1–5.8) 5.3 (5.1–5.7)
2hPG, mmol/l 6.1 (5.0–7.7) 6.2 (5.3–7.6)
FSI, pmol/l 7.4 (5.0–11.8) 10.0 (5.8–14.9)
2hSI, pmol/l 54.5 (31.5–87.9) 83.0 (58.9–114.4)
HOMA2-B 82.0 (65.0–109.8) 98.6 (70.7–127.1)
HOMA2-S 96.9 (62.8–142.5) 75.6 (50.8–126.6)
ISI0,120 70.8 (53.8–92.7) 62.6 (51.2–75.5)
Occupational grade, %
High 38 7
Intermediate 47 57
Low 15 36
Physical activity, %
Active 49 34
Moderately active 31 30
Inactive 19 35
Dietary pattern, %
Healthy 14 13
Moderately healthy 79 67
Unhealthy 7 20
Values are per cent or median (Q1–Q3)
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of the cubic trajectories was similar between the two ethnic
groups (Table 3).
In a sensitivity analysis comparing all models with and
without adjustment for age and BMI, the shapes of the trajec-
tories were very similar; only the intercept differences were
altered (data not shown).
Discussion
Repeat data from UK adults of European and South Asian
ethnic origin showed changes in glucose levels, insulin sensi-
tivity and insulin secretion several years before diabetes
diagnosis in both ethnic groups. FPG was found to increase
faster and reach higher values in South Asian compared with
white individuals. Insulin sensitivity levels were lower
throughout follow-up and fell more rapidly among South
Asian than among white individuals. A compensatory in-
crease in insulin secretion alongside decreasing insulin sensi-
tivity was observed among white individuals up to 7 years
before diagnosis. However, this trend was not seen in South
Asians, who already had higher insulin secretion levels
20 years before they were diagnosed with diabetes. This sug-
gests that they managed to compensate for their higher insulin
resistance for many years until a steep decline in insulin se-
cretion (and probable beta cell exhaustion) in the 5–7 years
Table 2 Mixed-effects models of change for FPG, 2hPG, FSI and 2hSI by ethnic group (comparing South Asian and white individuals)
FPG 2hPG FSI (loge) 2hSI (loge)
Model 1
Intercept 6.44 (6.34, 6.53)*** 11.31 (11.08, 11.54)*** 4.36 (4.31, 4.41)*** 6.08 (6.02, 6.14)***
SA 0.21 (0.00, 0.42)* 0.24 (−0.26, 0.74) 0.21 (0.07, 0.35)** 0.39 (0.22, 0.56)***
t 0.25 (0.21, 0.29)*** 1.26 (1.17, 1.35)*** 0.01 (0.00, 0.02)* 0.02 (0.02, 0.03)***
t × SA 0.022 (0.002, 0.042)* 0.022 (−0.024, 0.068) 0.029 (−0.001, 0.060) −0.005 (−0.020, 0.009)
t2 0.020 (0.015, 0.026)*** 0.102 (0.090, 0.114)*** −0.0009 (−0.0015, −0.0004)** –
t2 × SA – – 0.0018 (0.0002, 0.0035)* –
t3 0.0005 (0.0003, 0.0007)*** 0.0027 (0.0023, 0.032)*** – –
t3 × SA – – – –
Model 2
Intercept 6.39 (6.25, 6.52)*** 11.15 (10.83, 11.46)*** 4.32 (4.25, 4.38)*** 6.05 (5.96, 6.15)***
SA 0.27 (0.06, 0.48)* 0.39 (−0.11, 0.90) 0.33 (0.20, 0.45)*** 0.48 (0.32, 0.64)***
t 0.25 (0.21, 0.29)*** 1.26 (1.17, 1.35)*** 0.01 (−0.00, 0.02) 0.02 (0.01, 0.02)***
t × SA 0.022 (0.002, 0.042)* 0.021 (−0.025, 0.067) 0.022 (−0.005, 0.049) −0.006 (−0.020, 0.007)
t2 0.021 (0.015, 0.026)*** 0.103 (0.091, 0.115)*** −0.0006 (−0.0011, −0.0000)* –
t2 × SA – – 0.0014 (−0.0001, 0.0029) –
t3 0.0005 (0.0003, 0.0007)*** 0.0027 (0.0023, 0.0032)*** –
t3 × SA – – –
Values are model coefficients (95% CI)
Model 1: age (60 years), sex (male); model 2: age (60 years), sex (male), BMI (28 kg/m2 ), employment grade (intermediate), diet (moderately healthy),
physical activity (moderately active)
Insulin values were loge-transformed before analysis due to the skewed distribution
*p < 0.05, **p < 0.01, ***p < 0.001
SA, South Asian; t, time
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before diagnosis. In combination, these findings support the
hypothesis that South Asians exhibit long-term beta cell com-
pensation for chronic insulin resistance from childhood and
that they are unable to produce further beta cell compensation
in response to decreasing insulin sensitivity above 60 years of
age [3]. Whether these differences are innate or related to the
deleterious effects of some environmental factors is a question
that our study is currently unable to answer.
Our data support previous studies showing that the increase
in FPG before a diabetes diagnosis is rapid and occurs mostly
in the 3–4 years before diagnosis [14, 21–23], and when beta
cell dysfunction is present [15, 24, 25]. A novel finding of our
analysis is the steeper increasing FPG trajectory in South
Asians, suggesting a shorter window of opportunity for pre-
vention at any given FPG value. As clinical screenings were
performed at regular intervals in both South Asian and white
individuals, the lower rate of screen-detected diabetes among
South Asians is also compatible with the steeper increase in
FPG we observed. Given the potential for underdiagnosis
among South Asians, our graphs may therefore underestimate
the real slope differences. This supports our conjecture that
South Asians appear to have an accelerated development of
type 2 diabetes compared with white individuals.
In both ethnic groups, 2hPG followed a cubic in-
crease over time, with an approximate 5 mmol/l in-
crease in the last 8 years before diagnosis. Again, our
data support previous smaller scale studies showing a
rapid rise in 2hPG and a similar slope before diagnosis
[14, 21, 26]. The observed ethnic difference in the
2hPG slope was of the same magnitude as the FPG
slope. However, this translated to a much smaller, and
in the most adjusted model non-significant, relative dif-
ference between ethnicities. Whether this finding relates
to lifestyle or obesity or is simply a power issue re-
quires further study.
Our results confirm the essential role of low insulin
sensitivity in the development of incident diabetes [14].
We observed a decline in insulin sensitivity in both ethnic
groups as the cohort aged and a steep decrease in the
7 years preceding diagnosis among South Asians. South
Asian individuals had lower insulin sensitivity than white
individuals up to 20 years before they were diagnosed
with diabetes. This finding supports previous literature
showing decreased insulin sensitivity from a young age
among South Asians; this decrease appears decades before
the manifestation of diabetes [3, 7, 27, 28]. Plausible
Table 3 Mixed-effects models of change for HOMA2-B, HOMA2-S and ISI0,120 by ethnic group (comparing South Asian and white individuals)
HOMA2-B (loge) HOMA2-S (loge) ISI0,120 (loge)
Model 1
Intercept 4.39 (4.36, 4.44)*** 4.18 (4.13, 4.24)*** 3.63 (3.59, 3.67)***
SA 0.03 (−0.06, 0.12) −0.22 (−0.36, −0.08)** −0.10 (−0.19, −0.02)*
t −0.05 (−0.07, −0.04)*** −0.016 (−0.026, −0.006)** −0.14 (−0.16, −0.13)***
t × SA −0.007 (−0.014, −0.000)* −0.032 (−0.062, −0.001)* 0.001 (−0.007, 0.008)
t2 −0.005 (−0.007, −0.003)*** 0.0007 (0.0002, 0.0013)* −0.011 (−0.013, −0.009)***
t2 × SA – −0.0019 (−0.0036, −0.0002)* –
t3 −0.00011 (−0.00017, −0.00004)** – −0.0003 (−0.0003, −0.0002)***
t3 × SA – – –
Model 2
Intercept 4.39 (4.34, 4.45)*** 4.23 (4.16, 4.29)*** 3.66 (3.60, 3.71)***
SA 0.10 (0.02, 0.18)* −0.33 (−0.46, −0.21)*** −0.16 (−0.24, −0.07)***
t −0.052 (−0.066, −0.039)*** −0.012 (−0.021, −0.002)* −0.14 (−0.16, −0.13)***
t × SA −0.007 (−0.014, −0.001)* −0.024 (−0.051, 0.003) 0.001 (−0.006, 0.009)
t2 −0.005 (−0.006, −0.003)*** 0.0003 (−0.0002, 0.0009) −0.011 (−0.013, −0.009)***
t2 × SA – −0.0014 (−0.0029, 0.0001) –
t3 −0.00010 (−0.00016, −0.00004)** – −0.0003 (−0.0004, −0.0002)***
t3 × SA – – –
Values are model coefficients (95% CI)
Model 1: age (60 years), sex (male); model 2: age (60 years), sex (male), BMI (28 kg/m2 ), employment grade (intermediate), diet (moderately healthy),
physical activity (moderately active)
All outcome variables were loge-transformed before analysis due to the skewed distribution
*p < 0.05, **p < 0.01, ***p < 0.001
SA, South Asian; t, time
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explanations for the early emergence of decreased insulin
sensitivity include abdominal fat distribution and low mus-
cle mass, unhealthy lifestyles, low levels of adiponectin
and high levels of proinflammatory cytokines. Our multi-
variable analyses were adjusted for obesity (BMI), diet
and physical activity, yet the differences between the
South Asian and white participants remained for FPG
and measures of insulin sensitivity and secretion.
We observed higher levels of HOMA2-B among South
Asians compared with white individuals at baseline, probably
reflecting compensation for their lower insulin resistance. This
group had relatively stable FPG levels suggesting good
compensation for many years until a rapid decline in
insulin secretion in the 5–7 years before diagnosis, con-
tributing to the more rapidly increasing FPG trajectory.
This trend may be explained by a number of hypothe-
ses, including fetal undernutrition among Asian popula-
tions leading to reduced beta cell reserve (though per-
haps only among first-generation South Asians in our
study sample) [10], long-term beta cell compensation
for chronic insulin resistance from childhood [9], and/
or increasing FPG and 2hPG levels producing glucose
toxicity and consequent beta cell failure [12, 13].
Strengths and limitations We used repeat measures from a
large, occupational British cohort to compare ethnic dif-
ferences in trajectories of glycaemic measures prior to
diagnosis of type 2 diabetes. Data were collected over
23 years using robust standard operating procedures.
This long follow-up time allowed us to examine long-
term changes in a very well phenotyped cohort. There
was a change in the diagnostic criteria for diabetes in
the last period of the study (i.e. the introduction of
HbA1c). However, this is only expected to account for
a few cases of clinically diagnosed diabetes and is un-
likely to be differential by ethnic group. Relatedly,
while diabetes diagnosis was not confirmed by a repeat
OGTT, and we used the midpoint between study visits
as the date of (clinical) diagnosis of diabetes, we expect
this small risk of misclassification to be similar between
the two ethnic groups.
Our analysis approach allowed us to examine non-linear
patterns of change while taking into account the within-
person correlation arising from the longitudinal structure of
the data. Since gold standard measures of insulin sensitivity
are not feasible to use in large epidemiological studies, we
used the well-accepted and extensively validated HOMA in-
sulin sensitivity measure and the ISI0,120 index [18, 19]. Our
measure of HOMA insulin secretion is less widely used [18].
The HOMA models mostly reflect hepatic insulin resistance
and steady-state insulin secretion as they use fasting values for
estimation. By contrast, ISI0-120, which includes both fasting
and 2 h glucose and insulin concentrations, might be a better
reflection of whole-body insulin sensitivity. While hepatic in-
sulin resistance is strongly associated with fat and muscle
insulin resistance, elevated insulin secretion in the fasting state
is a late marker of beta cell dysfunction [29]. HOMA
insulin secretion only shows a moderate correlation with
first-phase insulin secretion and our findings may there-
fore represent an underestimation of early beta cell de-
compensation [18, 30]. We are unable to assess the
relative importance of hepatic and peripheral insulin re-
sistance in our two groups.
We used self-reported measures of physical activity and
dietary patterns rather than objectively measured covariates.
However, both these measures have previously been shown to
be associated with the risk of type 2 diabetes and all-cause
mortality in the Whitehall II cohort [31, 32]. Our study
population reflects the mix of people employed in the UK
civil service in the mid-1980s and consequently includes a
low number of South Asian individuals and an over-
representation of white-collar workers. This may somewhat
limit the generalisability of our findings, although ethnicity
was shown to be associated with incident diabetes in this
cohort, with similar relative risks to those of other
population-based studies [32]. Furthermore, we were un-
able to investigate whether fasting and 2 h glucose con-
centrations reflect different disease variants, due to the low
number of incident diabetes in South Asian participants
[15]. Finally, while we were able to adjust for a range
of confounders, we cannot rule out residual confounding
by unmeasured covariates such as birthweight and inflam-
matory markers.
In terms of public health recommendations, the earlier and
faster increases in FPG found in our study suggest a shorter
window for interventions to prevent type 2 diabetes in South
Asians. The clinical implications of our findings are less cer-
tain, although some speculate that incretin-based treatments
might be particularly suitable for South Asians with diabetes
[8].
Conclusions Our description of ethnic differences in glucose,
insulin, insulin sensitivity and insulin secretion before diabe-
tes diagnosis supports the growing literature suggesting that
there are important differences in the natural history of type 2
diabetes between South Asian and white individuals. Our
findings support a much earlier role of beta cell dysfunction
in South Asians, leading to rapidly increasing FPG trajectories
and an increased risk of diabetes. Compared with white indi-
viduals, the earlier and faster increases in FPG among South
Asians suggest that using the standard diabetes diagnosis cut-
off will find higher risk people who have advanced deteriora-
tion of both insulin sensitivity and secretion. Our results support
government recommendations to provide lifestyle intervention
at an earlier age and at lower glucose values among South
Asian populations.
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